Recent Press ReleasesApply09.23.2020FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI? (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma09.22.2020Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts09.18.2020Pfizer to Present Latest Scientific Advancements from Its Industry- Leading Portfolio at the ESMO Virtual Congress 202009.18.2020BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine09.15.2020Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas09.14.2020Pfizer Hosts Virtual Investor Day09.12.2020Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial09.11.2020Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference09.10.2020Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 202009.09.2020Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19Media ContactsGet to Know UsCompany Fact SheetFeatured StoriesPodcastsPress Kits @Pfizer @Pfizer_Newsby pfizerTweets by pfizer_news
